Perfusion Systems Global Market Report 2024

The perfusion systems market has grown rapidly in recent years. It will grow from $1.24 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth observed in the historical period owes much to foundational research in perfusion science, which laid the groundwork for understanding and advancing perfusion techniques. The introduction of hypothermia techniques was a significant milestone, allowing for the controlled cooling of the body during surgeries, which contributed immensely to the field of perfusion.

The perfusion systems market is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forthcoming period is primarily linked to a heightened emphasis on improving patient outcomes across medical procedures. Factors contributing to this include an upsurge in cardiovascular surgeries and the expanding realm of minimally invasive procedures, both of which are expected to drive the demand for perfusion systems. Additionally, the increased usage of extracorporeal membrane oxygenation (ECMO) is set to contribute significantly to this growth trajectory, along with ongoing developments in global healthcare infrastructure and the rising elderly population with specific healthcare needs.

The surge in organ transplants stands as a significant driving force behind the anticipated growth of the perfusion systems market. Organ transplants involve the surgical transfer of diseased or damaged organs from donors to recipients facing organ failure or disease. Perfusion systems play a vital role in this process by preserving and transporting organs, ensuring their viability during transplantation. Notably, data from the Organ Procurement and Transplantation Network in January 2021 indicated a 5.9% increase in organ transplants in the US, totaling 41,354 procedures, compared to the previous year. This uptick underscores the escalating demand driving the perfusion systems market due to the rising need for successful organ transplants.

The burgeoning aging population is poised to significantly contribute to the expansion of the perfusion systems market. With a notable rise in individuals aged 65 and above, this demographic often encounters age-related ailments leading to organ failure. Perfusions systems play a pivotal role in preserving and transporting organs for transplantation, elevating the likelihood of successful procedures. According to the World Health Organization's October 2022 data, the global population aged 60 and above reached 1.4 billion in 2022, projected to double to 2.1 billion by 2050. Additionally, individuals aged 80 or older are estimated to triple by 2050, reaching 426 million. This demographic shift is poised to drive the demand for perfusion systems, aligning with the increasing need for successful organ transplants amid an aging populace.

Product innovation emerges as a prominent trend within the perfusion systems market. Leading market players are channeling efforts into developing innovative solutions to fortify their market positions. An instance is LivaNova's February 2023 launch of the Essenz perfusion system in Europe. This system, known for its compact, modular, and portable design, is a cardiopulmonary bypass (CPB) system tailored for cardiac surgeries. Its modularity allows customization for diverse patient needs and surgical procedures, facilitating its versatility across clinical settings.

Major companies are innovating new products such as the PerSorb Adsorber and PerLife Organ Perfusion System to bolster their market profitability. These medical devices, exemplified by Cytosorbents Corporation's August 2021 launch, focus on organ ex vivo perfusion and purification during transplantation. The aim is to expand the pool of transplantable organs, including marginal organs impacted by complex biological processes during retrieval and transplantation. By enhancing organ preservation and transplant quality, these devices have the potential to revolutionize the field of organ transplantation, signaling a transformative leap in increasing transplantable organ supply and quality.

In December 2022, Merck & Co Inc., a prominent US-based pharmaceutical company, finalized the acquisition of Erbi Biosystems Inc. for an undisclosed sum. This strategic acquisition aims to facilitate the development of scalable cell-based perfusion bioreactor processes, initiating from as little as 2 ml. This move significantly strengthens Merck's upstream portfolio concerning therapeutic proteins. Among Merck's key growth drivers - referred to as its "Big 3," alongside the Life Science Services business unit, the Process Solutions business unit holds pivotal significance. The integration of Erbi Biosystems aligns with Merck's commitment to driving innovation within this specific business unit. Notably, Erbi Biosystems Inc. is a biotechnology tools company based in the United States.

Major companies operating in the perfusion systems market report are Getinge AB , Medtronic plc , LivaNova PLC , Terumo Corporation, Lifeline Scientific Inc., XVIVO Perfusion AB , Repligen Corporation , Spectrum Laboratories Inc. , Merck KGaA , Harvard Bioscience Inc. , ALA Scientific Instruments Inc. , Accuray Incorporated, XENIOS AG , General Healthcare Resources LLC, Siemens Healthcare Private Limited Shimadzu Corporation, Samsung Medison Co. Ltd., GENERAL ELECTRIC COMPANY, Organ Assist Products B.V., Shimadzu Corporation, Hitachi Ltd., Bioptechs Inc., Cytiva Company, Sorin Group, Organ Recovery Systems Inc., TransMedics Inc., Waters Medical Systems LLC, Paragonix Technologies Inc., Bridge to Life (Europe) Ltd., OrganOx Limited, Preservation Solutions Inc.

North America was the largest region in the perfusion systems market in 2023. The regions covered in the perfusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the perfusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

They come in various types, including cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and specialized variations. Cardiopulmonary perfusion systems specifically substitute the heart and lung functions temporarily during cardiac surgeries. These systems cater to diverse organs such as the heart, lungs, kidneys, liver, and others, employing techniques such as hypothermic and normothermic approaches. Their applications span across different healthcare settings, including hospitals, clinics, ambulatory surgical centers, and various other medical facilities.

The perfusion systems market research report provides perfusion systems market statistics, including perfusion systems industry global market size, regional shares, competitors with a perfusion systems market share, detailed perfusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion systems industry. This perfusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The perfusion systems market consists of revenues earned by entities by providing organ transplantation service, blood management services, cell isolation care, cardiac and respiratory disorders surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion systems market also includes sales of oxygenators, tubing, and filters equipment which are used in providing perfusion systems related services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.